Published in Exp Neurobiol on March 27, 2014
Therapeutic Effects of Bee Venom on Immunological and Neurological Diseases. Toxins (Basel) (2015) 0.80
Bee Venom Acupuncture Augments Anti-Inflammation in the Peripheral Organs of hSOD1G93A Transgenic Mice. Toxins (Basel) (2015) 0.79
An Introduction to the Toxins Special Issue on "Bee and Wasp Venoms: Biological Characteristics and Therapeutic Application". Toxins (Basel) (2016) 0.75
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis. Curr Neuropharmacol (2016) 0.75
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 18.08
ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron (2006) 7.82
Bee and wasp venoms. Science (1972) 7.35
From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci (2001) 6.48
Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci (2006) 4.30
Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci (2007) 3.02
Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve (2002) 2.25
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol (1992) 2.01
Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology (2001) 2.01
Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum (2004) 1.89
Melittin: a membrane-active peptide with diverse functions. Biosci Rep (2007) 1.70
CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol (2006) 1.66
Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS One (2008) 1.65
Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des (2007) 1.41
A proposed transpositional acupoint system in a mouse and rat model. Res Vet Sci (2007) 1.41
Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 1.35
JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm (Lond) (2008) 1.30
Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol (2004) 1.27
Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta (2006) 1.26
Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. J Neuroinflammation (2013) 1.21
Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol (1990) 1.20
Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr Opin Immunol (2003) 1.09
MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol (2006) 1.05
Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS. PLoS One (2011) 1.00
Immunity to self and self-maintenance: a unified theory of brain pathologies. Trends Immunol (2008) 1.00
Murine CD8+ regulatory T lymphocytes: the new era. Hum Immunol (2008) 0.99
Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression. J Pharmacol Exp Ther (2006) 0.98
Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice. J Neuropathol Exp Neurol (2004) 0.96
Melittin restores proteasome function in an animal model of ALS. J Neuroinflammation (2011) 0.91
Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology (1996) 0.90
Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand (1988) 0.90
Anti-inflammatory effects of electroacupuncture in the respiratory system of a symptomatic amyotrophic lateral sclerosis animal model. Neurodegener Dis (2011) 0.90
Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens. Clin Exp Immunol (1982) 0.89
Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis. Curr Opin Investig Drugs (2002) 0.83